Han Ying
Clinical trials sponsored by Han Ying, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a cholesterol drug help fight a rare liver disease? Results expected Sep 2026 (estimated)
-
Could a cholesterol drug help fight a rare liver disease?
Disease control OngoingThis study tests whether adding fenofibrate (a drug used for high cholesterol) to standard treatment with ursodeoxycholic acid can improve liver health in people with primary biliary cholangitis (PBC), a rare autoimmune liver disease. About 184 adults with PBC will receive either…
Phase 2/3 • Sponsor: Han Ying • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New hope for Hard-to-Treat liver disease: steroid combo trial launches
Disease control By invitation onlyThis study looks at whether adding prednisone to standard UDCA treatment helps people with primary biliary cholangitis (PBC) who also have moderate to severe interface hepatitis, a type of liver inflammation. About 244 adults will be randomly assigned to receive either UDCA alone…
Phase 2/3 • Sponsor: Han Ying • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC